Publication Name	World Journal of Gastroenterology
Manuscript ID	118370
Country	China

Category	Gastroenterology & Hepatology
Manuscript Type	Editorial
Article Title	Percutaneous vs surgical management of hepatic cystic echinococcosis: A perspective on evolving clinical pathways
Manuscript Source	Invited Manuscript
All Author List	Xin-Ying Zhang, Bao-Qi Li, Wen-Na Cao, Zi-Li Zhang, Qi Xin and Ke-Feng Jia
Funding Agency and Grant Number	Funding Agency Grant Number Tianjin Science and Technology Project 24JCZDJC01270 Tianjin Third Central Hospital Research Project 2019YNR3 Beijing Medical Award Foundation YXJL-2020-0972-1216 Tianjin Health Science and Technology Project TJWJ2024MS023 Tianjin Municipal Education Commission Scientific Research Project 2025ZXZD002
Corresponding Author	Ke-Feng Jia, Department of Interventional Radiology, Central Hospital, Tianjin University/Tianjin Third Central Hospital, No. 83 Jintang Road, Hedong District, Tianjin 300170, China. jiakefeng20102@163.com
Key Words	Cystic echinococcosis; Percutaneous treatment; Surgical management; Clinical pathways; Zoonotic disease; Echinococcus granulosus; Hydatid cyst
Core Tip	Hepatic cystic echinococcosis management is less challenged by a lack of therapeutic options than by rational, cyst-specific decision-making. Percutaneous interventions are safe and effective for cysts classified by World Health Organization as CE1 and CE3a, offering advantages in efficiency; while surgery remains essential for large cysts and those with complex biliary involvement or high-risk anatomy. Large real-world data further identify cyst volume as a major determinant of biliary complications, independent of treatment modality. Rather than competing strategies, percutaneous and surgical approaches should be integrated into dynamic, risk-adapted clinical pathways guided by cyst biology, anatomy, and procedural burden.
Citation	Zhang XY, Li BQ, Cao WN, Zhang ZL, Xin Q, Jia KF. Percutaneous vs surgical management of hepatic cystic echinococcosis: A perspective on evolving clinical pathways. World J Gastroenterol 2026; In press

Received	2025-12-31 00:52
Peer-Review Started	2025-12-31 00:53
First Decision by Editorial Office Director	2026-01-28 09:24
Return for Revision	2026-01-28 09:24
Revised	2026-02-06 11:52
Publication Fee Transferred
Second Decision by Editor	2026-03-06 02:34
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director	2026-03-06 08:13
Articles in Press	2026-03-06 08:13
Edit the Manuscript by Language Editor
Typeset the Manuscript

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com